Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Feb 14, 2022

BUY
$5.21 - $6.82 $424,094 - $555,148
81,400 Added 6.57%
1,320,100 $8.69 Million
Q3 2021

Nov 15, 2021

BUY
$5.25 - $5.87 $6.5 Million - $7.27 Million
1,238,700 New
1,238,700 $6.57 Million
Q3 2021

Nov 15, 2021

SELL
$5.25 - $5.87 $4.23 Million - $4.73 Million
-806,500 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$5.67 - $6.33 $4.57 Million - $5.11 Million
806,500 New
806,500 $4.69 Million

Others Institutions Holding KMDA

About KAMADA LTD


  • Ticker KMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 44,800,500
  • Market Cap $264M
  • Description
  • Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...
More about KMDA
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.